对接受标准治疗的阿尔波特综合征患者进行前性队列研究
Oliver Gross1, Michelle N Rheault2, James Simon3
1University Medical Center Goettingen, Nephrology and Rheumatology, Goettingen, Germany.
Kidney international reports
|June 9, 2025
概括
阿尔波特综合征 (AS) 患者表现出与尿中的白蛋白与肌素比率 (UACR) 相关的快速功能下降. 这项研究为未来的阿尔波特综合征治疗试验提供了数据.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 遗传学 是一个遗传学.
- 临床试验 临床试验
背景情况:
- 阿尔波特综合征 (AS) 是一种常见的遗传性病,进展变化.
- 了解AS进展对于设计有效的干预试验至关重要.
研究的目的:
- 为设计未来对阿尔波特综合征的干预试验生成数据.
- 描述AS患者功能下降的进展情况.
主要方法:
- 一个全球性的,多中心的,前性的观察性研究.
- 165名12-65岁的确诊AS和eGFR45-90毫升/分钟的患者进行了长达120周的随访.
- 收集的数据包括血液/尿液样本,病史,基因型,不良事件和结果.
主要成果:
- 基线尿白蛋白与肌素比率 (UACR) >1g/g预测快速EGFR下降 (斜率-10.16毫升/分钟/年).
- 年度eGFR斜率因AS类型而异: -6.7在X结合的男性中,0.6在X结合的女性中,-1.66在自体患者中.
- 与AS相关的不良事件很少发生 (在353个AE中占7.4%).
结论:
- 在AS中,功能快速下降与UACR相关.
- 与AS相关的不良事件在标准护理下不常见.
- 研究结果支持未来阿尔波特综合征干预试验的设计.
更多相关视频
相关概念视频
Nephrotic Syndrome II : Assessment and Medical Management
2
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
2
Nephrotic Syndrome III : Nursing Management
2
Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
2


